Nepal keeps its vax deal with China under wraps
June 17, 2021  16:03
image
Nepal is set to buy four million doses of the Chinese Sinopharm vaccine amid its fight the second wave of the COVID-19 pandemic, local media reported. However, details like the price and delivery date have been kept under wraps.

The Kathmandu Post reported that the vaccines would be bought under a non-disclosure agreement, as proposed by Sinopharm, raising concerns among many people in the Himalayan nation. 

The Nepali daily newspaper reported a minister as saying that two doses of the Chinese vaccine are likely to cost around USD 20. According to a country's health ministry official, USD 20 for two doses would still be pricey for Nepal when compared to what deal it got for the USD 4 AstraZeneca vaccine from the Serum Institute of India.

Last week, Bangladesh had signed a deal with China to buy the Sinopharm Covid-19 vaccine, without disclosing the price or quantity of doses, Dhaka Tribune reported.
« Back to LIVE

TOP STORIES